New horizons in treatment of osteoporosis. - Test2 - elhamkhani - TriplyDB

New horizons in treatment of osteoporosis.

New horizons in treatment of osteoporosis.

http://www.wikidata.org/entity/Q37630995

about

Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro.Intermittent activation of notch signaling promotes bone formation.Modulation of Calcitonin, Parathyroid Hormone, and Thyroid Hormone Secretion by Electrical Stimulation of Sympathetic and Parasympathetic Nerves in Anesthetized Rats.Optimization of the Time Window of Interest in Ovariectomized Imprinting Control Region Mice for Antiosteoporosis Research.Autophagy Maintains the Function of Bone Marrow Mesenchymal Stem Cells to Prevent Estrogen Deficiency-Induced Osteoporosis.Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review.Pharmacological Therapy of Osteoporosis: A Systematic Current Review of Literature.Evaluation of the electromyographic fatigue of the masseter and temporalis muscles in individuals with osteoporosis.Osteoporosis: Current Concepts Boldine Ameliorates Estrogen Deficiency-Induced Bone Loss via Inhibiting Bone Resorption Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial

P2860

Q33742422-A1478CA8-E879-4680-9686-A9D8E8CB0191 Q33850283-B95EC8AA-3E39-4811-AC4E-B4FCC536E5A8 Q40995778-80EA475E-ABDE-46B0-A51F-F57A2B4ED903 Q44129624-1FD1900E-0C93-458C-8E8E-2A5013212986 Q47154773-401D746A-6DBA-485B-98B1-E178E360B9E0 Q47400369-3EDBC558-0D85-4579-9EEC-DEE259FCB002 Q49165503-5E512AE3-D969-4DA0-ADE2-E46A4C195B31 Q50071815-E96022ED-7DBD-4DB3-90E7-956CA20A8677 Q56379389-3659097F-BB7A-4746-8E16-D4B466B5F3D6 Q57111009-4197546C-469D-4B13-90F5-0D66F19AB0EB Q57494538-13ABEB25-A454-49A2-902D-34DD0AAACEF6

P2860

New horizons in treatment of osteoporosis.

http://www.wikidata.org/entity/Q37630995

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New horizons in treatment of osteoporosis.

@en

New horizons in treatment of osteoporosis.

@nl

type

label

New horizons in treatment of osteoporosis.

@en

New horizons in treatment of osteoporosis.

@nl

prefLabel

New horizons in treatment of osteoporosis.

@en

New horizons in treatment of osteoporosis.

@nl

P1433

Q37630995-949F08B7-0EC2-4677-9DAB-E6136D13F16C

P1476

Q37630995-F616CFDE-2010-4E95-8BC1-87E0112E785D

P2093

Q37630995-4C106094-9F05-456D-AC60-73C92535A46F

P275

Q37630995-DE2675B4-BEE7-4D98-B8D1-496FBB429E9C

P2860

Q37630995-019B32C6-907E-439C-B651-36C2160EE882

Q37630995-03754A20-EF2B-494B-A4C0-399F80F1709D

Q37630995-04E199E6-EE07-42A3-9F24-A9A3BB276A15

Q37630995-053905C3-1C31-4608-8930-8BAC8A1706B9

Q37630995-075A01A8-9E57-4231-9166-120585D2B86B

Q37630995-0937F1E9-9F1D-4320-A266-275115B439F8

Q37630995-0B43D836-31B2-4C84-86D1-0461562D8531

Q37630995-0CF83704-BDC9-4FF3-A6DD-0FD89CC9A6DF

Q37630995-0D54A249-F3B5-4B5C-9499-A7DD6404CCB8

Q37630995-0D8504AA-B8C9-405E-A811-20DA959BF17E

P2888

Q37630995-74E0DAC9-CE55-4364-BDBA-95551C5E6850

P304

Q37630995-D72F79EE-D6CF-415A-AD8D-F866EC4816EA

P31

Q37630995-47C1F9AF-2E9A-4602-9651-0B5014B02F95

P356

Q37630995-8F1C4887-CF59-457C-A82F-B352D10B1458

P407

Q37630995-DCBFF46A-DF63-46EE-9FCF-11780006C4F8

P433

Q37630995-040A424D-A409-418B-9BA7-FE1E7ADCD86B

P478

Q37630995-A8D64699-ACF1-4450-9AFF-32A7CDC9B879

P50

Q37630995-7D5283EB-B1E6-4FC2-AC8C-A24576F123BA

Q37630995-B991CA04-7777-42AE-987D-0BB06E1C2E53

Q37630995-DABF4BE5-DDA7-440F-B493-ECDFF9B1E583

P5008

Q37630995-67EDE68C-E03E-4FC2-9E89-B62571506DF3

P577

Q37630995-96748A71-E986-4D04-A766-AC9E29CF9D39

P6179

Q37630995-47916711-A78D-45A3-8BF4-76B0813A1087

P698

Q37630995-52334464-88ED-46CC-804A-36F8A595EC0A

P921

Q37630995-2A157FA9-E48C-446F-8D4D-3AD8E5788792

P932

Q37630995-E2F50287-E768-42E1-9D56-14E3240EFD71

P356

S40199-017-0167-Z

P1433

P1476

New horizons in treatment of osteoporosis

@en

P2093

Bagher Larijani

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Strontium ranelate for preventing and treating postmenopausal osteoporosis

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges

The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

Lasofoxifene in postmenopausal women with osteoporosis

P2888

s40199-017-0167-z

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40199-017-0167-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Khashayar

P5008

P577

2017-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083720114

http://www.w3.org/2001/XMLSchema#string

P698

28173850

http://www.w3.org/2001/XMLSchema#string

P921

P932

5297185

http://www.w3.org/2001/XMLSchema#string